Search Results

You are looking at 1 - 10 of 124 items for :

  • "hepatitis" x
Clear All
Full access

Bhumsuk Keam, Jeong-Hoon Lee, Seock-Ah Im and Jung-Hwan Yoon

Epidemiology of Hepatitis B Virus Hepatitis B virus (HBV) has infected more than 2 billion people worldwide, and approximately 350 million patients worldwide have chronic HBV infection. 1 , 2 In the United States, carriers of chronic

Full access

Laura M. Kulik

. Secondary prevention of hepatitis c virus-related hepatocellular carcinoma [editorial] . J Gastroenterol Hepatol 2005 ; 20 : 1475 – 1477 . 6. Yao FY Bass NM Nikolai B . A follow-up analysis of the pattern and predictors of dropout from the

Full access

Caitlin A. Hester, Nicole E. Rich, Amit G. Singal and Adam C. Yopp

the United States. 1 – 4 Typically occurring in a background of chronic liver disease and cirrhosis, the most common risk factors worldwide have traditionally included hepatitis B virus (HBV), hepatitis C virus (HCV), and alcohol-related liver disease

Full access

Harrys A. Torres, Parag Mahale, Boris Blechacz, Ethan Miller, Ahmed Kaseb, H. Franklin Herlong, Nathan Fowler, Ying Jiang, Issam I. Raad and Dimitrios P. Kontoyiannis

Background Approximately 130 to 170 million persons globally are infected with hepatitis C virus (HCV). 1 In the United States, approximately 2.7 to 3.9 million persons (1.0%–1.5%) are infected. 2 Chronic HCV increases the risk for mortality

Full access

Harrys A. Torres, Lillian R. Roach, Parag Mahale, Minas P. Economides, Boris Blechacz, Ethan Miller, Roy Borchardt, Anis Rashid, Thein H. Oo, Bhavarth Shukla, Malik Farida, Charles D. Ericsson, Bruno P. Granwehr and Issam I. Raad

Hepatitis C virus (HCV) infection is a major problem worldwide, with 230 million reported cases, including 2.7 to 3.9 million cases (1.0%–1.5%) in the United States. 1 The prevalence rates for HCV infection in patients with cancer range from 1

Full access

Kwang-Yu Chang, Jang-Yang Chang and Yun Yen

States: a case-control study . Gastroenterology 2005 ; 128 : 620 – 626 . 12 Hsing AW Zhang M Rashid A . Hepatitis B and C virus infection and the risk of biliary tract cancer: a population-based study in China . Int J Cancer 2008 ; 122

Full access

Sowmya Boddhula, Satish Kumar Boddhula, Bishesh Shrestha, Kelly Morris and Rosana Gnanajothy

Introduction: Individuals with chronic hepatitis B virus infection (HBV) or previous infection with HBV are at increased risk of HBV exacerbation or reactivation when they receive treatment with anti-CD20 monoclonal antibodies like rituximab (RTX

Full access

Ghassan K. Abou-Alfa

Engl J Med 2008 ; 359 : 378 – 390 . 3 Huitzil-Melendez FD Saltz LB Song J , et at. Retrospective analysis of outcome in hepatocellular carcinoma (HCC) patients (pts) with hepatitis C (C+) versus B (B+) treated with sorafenib (S) [abstract

Full access

Sarah P. Hammond, Sankar Swaminathan, William I. Bensinger and Lindsey R. Baden

An estimated 2 billion people worldwide have been infected with hepatitis B virus (HBV). Of those, an estimated 240 million have chronic HBV infection. 1 , 2 In the United States, where HBV is nonendemic, an estimated 1.4 million people have

Full access

Presenter : Stephen D. Smith

etiology of MZL, current treatment standards by subtype, and the role of targeted therapies ( Figure 1 ). Figure 1. Diagnosis of MZLs. Abbreviations: BM, bone marrow; CLL, chronic lymphocytic leukemia; HBV, hepatitis B virus; HCV, hepatitis C virus; FL